| Literature DB >> 36183050 |
Gaby J Ritfeld1,2, Julie A Kable3,4, Jennifer E Holton3, Claire D Coles3,4.
Abstract
Fetal Alcohol Spectrum Disorders affect up to 5% of the population, with additional children affected by prenatal drug exposures. The majority of these children display symptoms of ADHD and poor emotional dysregulation, a common reason for seeking psychiatric care. However, high prevalence of comorbid look-alike symptoms and limited availability of evidence-based treatments complicates psychiatric decision making in this population. The goal of the current study is to report on the effectiveness of psychotropic medications in a case series of 16 individuals with prenatal alcohol/drug exposure and propose a model for psychiatric care for this population. In addition to traditional subjective reports, an objective continuous performance test (T.O.V.A.®) was used to aid with guiding treatment. We found that T.O.V.A.®-scores improved on average from - 6.5 to - 2.9 with our psychiatric approach (p = 0.03). T.O.V.A.®-measurements were helpful in differentiating ADHD symptoms from comorbid symptoms and to guide decision-making on starting and changing medications.Entities:
Keywords: Fetal Alcohol Spectrum Disorder; Model of care; Prenatal substance exposure; Psychotropic medication
Year: 2022 PMID: 36183050 DOI: 10.1007/s10578-022-01451-3
Source DB: PubMed Journal: Child Psychiatry Hum Dev ISSN: 0009-398X